Effect of Pardihan” syrup on platelet count

Phase 3

Recruiting

• Conditions: Patients with thrombocytopenia.; Thrombocytopenia, unspecified; D69.6

• Registration Number: IRCT20081024001391N3
• Lead Sponsor: Shahed University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 June 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

All patients with a diagnosis of thrombocytopenia
Signing a informed consent form
Age over 18 years

Exclusion Criteria

History of allergy to medicinal plants components
Use of nplate drug

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Platelet counts and hemoglobin. Timepoint: Take the drug for 4 weeks. Measurements are taken after 2, 4 and 6 weeks. Method of measurement: Blood test (CBC).

Secondary Outcome Measures

Name	Time	Method
Quality of Life. Timepoint: Before starting the study; After 6 weeks (end of study). Method of measurement: World Health Organization Quality of Life Questionnaire 26 questions.